Advertisement

U.S. markets open in 12 minutes

S&P Futures
4,684.50
-14.50(-0.31%)
Dow Futures
35,626.00
-120.00(-0.34%)
Nasdaq Futures
16,333.75
-58.50(-0.36%)
Russell 2000 Futures
2,254.70
-15.10(-0.67%)
Crude Oil
71.64
-0.72(-1.00%)
Gold
1,777.20
-8.30(-0.46%)

Advertisement

JUST IN

New weekly jobless claims hit lowest level since 1969

Another 184,000 Americans filed new claims, 220,000 expected

Barratt Developments plc (BTDPY)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

19.67

+0.35

(+1.79%)

At close: 03:45PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	19.32
Open	19.56
Bid	0.00 x 0
Ask	0.00 x 0
Day's Range	19.56 - 19.72
52 Week Range	15.34 - 23.86
Volume	159,311
Avg. Volume	35,371

Market Cap	10.053B
Beta (5Y Monthly)	1.54
PE Ratio (TTM)	11.59
EPS (TTM)	1.70
Earnings Date	N/A
Forward Dividend & Yield	0.81 (4.10%)
Ex-Dividend Date	Sep 30, 2021
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BTDPY

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

BARRATT DEVELOPMENTS
Analyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Rating
Fair Value
Economic Moat
3 days agoMorningstar

All

News

Press Releases

Research Reports

Simply Wall St.
Is Barratt Developments plc's (LON:BDEV) Recent Stock Performance Influenced By Its Financials In Any Way?
Most readers would already know that Barratt Developments' (LON:BDEV) stock increased by 4.5% over the past week. Given...
Simply Wall St.
Is Barratt Developments (LON:BDEV) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
MarketWatch
SoftBank-backed THG reels further after saying it can’t explain stock-price decline
THG shares failed to bounce back Wednesday after the internet retailer said it couldn't explain why the stock dropped so heavily during its capital markets day.